Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Allurion Technologies Inc. (ALUR:NYSE), powered by AI.
Allurion Technologies Inc. is currently trading at $0.99. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Allurion Technologies Inc. on Alpha Lenz.
Allurion Technologies Inc.'s P/E ratio is -0.3.
“Allurion Technologies Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 37.1%.”
Ask for details →Allurion Technologies Inc. is a healthcare-focused company dedicated to developing non-invasive medical devices and technology solutions aimed at promoting weight loss and healthy living. The cornerstone of Allurion's offerings is the Elipse Balloon, a swallowable, intragastric balloon designed to aid in weight loss without the need for surgery or endoscopic procedures. This innovative device gradually inflates within the stomach, providing a temporary sense of fullness to patients, which helps reduce food intake. Allurion operates primarily within the medical technology and wellness sectors, targeting a global market that includes hospitals, clinics, and wellness centers. With obesity being a significant health concern worldwide, Allurion's non-surgical solutions garner attention for their potential impact on improving patient outcomes while reducing healthcare costs associated with obesity-related conditions. The company continues to evolve its technological platforms, incorporating digital tools to monitor and support patients throughout their weight loss journey, cementing its position in the intersection of health, technology, and consumer healthcare markets.
“Allurion Technologies Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 37.1%.”
Ask for details →Allurion Technologies Inc. (ticker: ALUR) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 134 employees. Market cap is $7M.
The current price is $0.99 with a P/E ratio of -0.26x and P/B of -0.1x.
ROE is 37.06% and operating margin is -198.01%. Annual revenue is $15M.